The human cardiovascular system operates through a finely tuned mechanism regulated by intricate physiological processes. The heart's rhythmic contractions, orchestrated by electrical signals, drive the continuous circulation of blood. The cardiac cycle involves systole, where the heart contracts to pump blood, and diastole, the relaxation phase allowing the heart chambers to fill. The systemic and pulmonary circulations work in tandem, with the left side of the heart pumping oxygenated blood to the body and the right side pumping deoxygenated blood to the lungs for oxygen exchange. Blood pressure, maintained by the elasticity of blood vessels, ensures a steady flow of blood throughout the circulatory system. Hormones, such as adrenaline and angiotensin, contribute to the regulation of blood volume and vessel tone. Disorders of the cardiovascular system, such as hypertension, atherosclerosis, or arrhythmias, can impact its efficiency, leading to various health complications. Understanding the intricacies of the human cardiovascular system is fundamental to promoting heart health and addressing cardiovascular diseases that affect millions of people worldwide.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India